Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bates

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
British Journal of Cancer|November 28, 2019
FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancerStephanie Annett, Gillian Moore, Amy Short, et al.
Cell Death and Differentiation|September 9, 2017
MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cellsGomaa Sulaiman, Aoife Cooke, Brendan Ffrench, et al.
Translational Oncology|September 30, 2021
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenonCathy D Spillane, Niamh M Cooke, Mark P Ward, et al.
Plos One|July 1, 2014
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancerCharles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, et al.
Scientific Reports|August 18, 2023
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progressionJoanna Lazniewska, Ka Lok Li, Ian R D Johnson, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
British Journal of Cancer|November 28, 2019
FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancerStephanie Annett, Gillian Moore, Amy Short, et al.
Cell Death and Differentiation|September 9, 2017
MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cellsGomaa Sulaiman, Aoife Cooke, Brendan Ffrench, et al.
Translational Oncology|September 30, 2021
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenonCathy D Spillane, Niamh M Cooke, Mark P Ward, et al.
Plos One|July 1, 2014
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancerCharles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, et al.
Scientific Reports|August 18, 2023
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progressionJoanna Lazniewska, Ka Lok Li, Ian R D Johnson, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 7